Cat.#: ACPP-1367
| Despition | Myocilin Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1179 | Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) (AC1179) | 50 µg | inquiry |
| ACPP-1479 | Human TIMP1 Protein, HEK (AC1479) | 2 µg | inquiry |
| ACPP-1535 | Human VAMP8 Protein (AC1535) | 5 µg | inquiry |
| ACPP-1599 | Human CHGB Protein (AC1599) | 2 µg | inquiry |
| ACPP-1677 | Mouse S100A8 Protein (AC1677) | 5 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1662 | Human POFUT1 Protein (AC1662) | 5 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
| ACPP-1434 | Human CD34 Protein, GST (AC1434) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.